Bharat [BIBCL] vs Dishman Carbogen [DCAL] Detailed Stock Comparison

Bharat

Dishman Carbogen
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Bharat wins in 2 metrics, Dishman Carbogen wins in 15 metrics, with 0 ties. Dishman Carbogen appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Bharat | Dishman Carbogen | Better |
---|---|---|---|
P/E Ratio (TTM) | -5.48 | 42.71 | Bharat |
Price-to-Book Ratio | 1.16 | 0.76 | Dishman Carbogen |
Debt-to-Equity Ratio | 94.48 | 40.97 | Dishman Carbogen |
PEG Ratio | -0.09 | -0.33 | Dishman Carbogen |
EV/EBITDA | -7.87 | 10.68 | Bharat |
Profit Margin (TTM) | -241.59% | 3.60% | Dishman Carbogen |
Operating Margin (TTM) | -2,888.44% | 8.38% | Dishman Carbogen |
EBITDA Margin (TTM) | N/A | 8.38% | N/A |
Return on Equity | -21.00% | 0.06% | Dishman Carbogen |
Return on Assets (TTM) | -6.28% | 0.03% | Dishman Carbogen |
Free Cash Flow (TTM) | $108.92M | $1.58B | Dishman Carbogen |
1-Year Return | -21.99% | 57.44% | Dishman Carbogen |
Price-to-Sales Ratio (TTM) | 11.76 | 1.54 | Dishman Carbogen |
Enterprise Value | $1.56B | $63.19B | Dishman Carbogen |
EV/Revenue Ratio | 20.45 | 2.18 | Dishman Carbogen |
Gross Profit Margin (TTM) | N/A | 86.15% | N/A |
Revenue per Share (TTM) | $2 | $188 | Dishman Carbogen |
Earnings per Share (Diluted) | $-4.18 | $6.65 | Dishman Carbogen |
Beta (Stock Volatility) | 0.91 | 0.17 | Dishman Carbogen |
Bharat vs Dishman Carbogen Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Bharat | 0.28% | -1.73% | -4.53% | -11.28% | -1.73% | -13.82% |
Dishman Carbogen | 2.71% | 6.48% | 2.11% | 8.18% | 50.32% | 0.86% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Bharat | -21.99% | -13.47% | -4.44% | -27.59% | 5.61% | -10.34% |
Dishman Carbogen | 57.44% | 186.03% | 83.63% | 58.10% | 226.17% | 284.95% |
News Based Sentiment: Bharat vs Dishman Carbogen
Bharat
News based Sentiment: MIXED
The month's developments present a mixed picture for Bharat Immunologicals & Biologicals Corporation. While the share price showed a slight increase and the company continues to diversify its product line, the overall year-long decline and price volatility create uncertainty for investors.
Dishman Carbogen
News based Sentiment: POSITIVE
Dishman Carbogen Amcis Ltd. reported a significant turnaround in profitability and revenue growth, coupled with increased institutional investment and a 'Buy' recommendation from analysts. These developments collectively signal a positive shift in the company's prospects, making it a noteworthy story for investors.
Performance & Financial Health Analysis: Bharat vs Dishman Carbogen
Metric | BIBCL | DCAL |
---|---|---|
Market Information | ||
Market Cap | ₹910.67M | ₹45.33B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 16,386 | 737,916 |
90 Day Avg. Volume | 25,808 | 386,098 |
Last Close | ₹21.13 | ₹295.55 |
52 Week Range | ₹19.00 - ₹35.88 | ₹161.21 - ₹321.95 |
% from 52W High | -41.11% | -8.20% |
All-Time High | ₹94.50 (Jun 14, 2021) | ₹396.40 (Jan 22, 2018) |
% from All-Time High | -77.64% | -25.44% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.99% | 0.35% |
Quarterly Earnings Growth | -1.00% | 0.35% |
Financial Health | ||
Profit Margin (TTM) | -2.42% | 0.04% |
Operating Margin (TTM) | -28.88% | 0.08% |
Return on Equity (TTM) | -0.21% | 0.00% |
Debt to Equity (MRQ) | 94.48 | 40.97 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹18.24 | ₹372.17 |
Cash per Share (MRQ) | ₹2.07 | ₹33.89 |
Operating Cash Flow (TTM) | ₹87.48M | ₹-199,700,000 |
Levered Free Cash Flow (TTM) | ₹-166,388,000 | ₹32.40M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Bharat vs Dishman Carbogen
Metric | BIBCL | DCAL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -5.48 | 42.71 |
Forward P/E | N/A | 22.72 |
PEG Ratio | -0.09 | -0.33 |
Price to Sales (TTM) | 11.76 | 1.54 |
Price to Book (MRQ) | 1.16 | 0.76 |
Market Capitalization | ||
Market Capitalization | ₹910.67M | ₹45.33B |
Enterprise Value | ₹1.56B | ₹63.19B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 20.45 | 2.18 |
Enterprise to EBITDA | -7.87 | 10.68 |
Risk & Other Metrics | ||
Beta | 0.91 | 0.17 |
Book Value per Share (MRQ) | ₹18.24 | ₹372.17 |
Financial Statements Comparison: Bharat vs Dishman Carbogen
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | BIBCL | DCAL |
---|---|---|
Revenue/Sales | ₹0 | ₹7.08B |
Cost of Goods Sold | ₹0 | ₹980.90M |
Gross Profit | ₹0 | ₹6.10B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-47.23M | ₹593.30M |
EBITDA | ₹-45.25M | ₹1.65B |
Pre-Tax Income | ₹-66.46M | ₹386.70M |
Income Tax | ₹-17.28M | ₹152.60M |
Net Income (Profit) | ₹-49.18M | ₹234.10M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | BIBCL | DCAL |
---|---|---|
Cash & Equivalents | ₹14.58M | ₹2.86B |
Total Current Assets | ₹327.10M | ₹22.00B |
Total Current Liabilities | ₹990.55M | ₹19.25B |
Long-Term Debt | ₹35.00M | ₹13.90B |
Total Shareholders Equity | ₹787.09M | ₹58.32B |
Retained Earnings | N/A | ₹2.13B |
Property, Plant & Equipment | N/A | ₹10.27B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | BIBCL | DCAL |
---|---|---|
Operating Cash Flow | ₹-708.65M | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | ₹-456.88M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | BIBCL | DCAL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 16,386 | 737,916 |
Average Daily Volume (90 Day) | 25,808 | 386,098 |
Shares Outstanding | 43.18M | 156.78M |
Float Shares | 17.58M | 55.22M |
% Held by Insiders | 0.59% | 0.71% |
% Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Bharat vs Dishman Carbogen
Metric | BIBCL | DCAL |
---|---|---|
Last 12-Month Dividend | N/A | ₹0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | ₹0.00 |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | ₹0.00 |
Ex-Dividend Date | N/A | N/A |